The Science Behind the Headlines

Alzheimer’s Disease: A Tough Nut To Crack

Alzheimer’s Disease: A Tough Nut To Crack

Alzheimer's disease: A tough nut to crack September 21 is World Alzheimer’s Day, a day focused on raising awareness of Alzheimer’s disease (AD). This week and next, we’ll review what is known about AD, and summarize novel treatments in development. Alzheimer’s disease...

read more

The free Biotech Primer WEEKLY explains the science behind today’s headlines. Delivered each Thursday directly to your inbox.

Subscribe to The WEEKLY today.

Gene Therapy Targets AIDS

Gene Therapy Targets AIDS

Gene Therapy Targets AIDS For many years, a diagnosis of acquired immunodeficiency syndrome (AIDS) was a death sentence. It seemed unthinkable in the 1980s, but the medical community now largely treats the disease as a chronic illness. This profound shift arose...

read more

Biotech for Non-Scientists

From Drug Discovery To Approval: Phase IV

From Drug Discovery To Approval: Phase IV

Pharma Finish Line: FDA Approval Last week, we focused on the final stage of clinical testing, Phase III trials, where drug developers assess the safety and efficacy of their drug in large patient groups. At the end of Phase III, drug developers face the moment of...

read more
An Egg-cellent Idea

An Egg-cellent Idea

An Egg-cellent Idea "The incredible, edible egg." This advertising slogan created for the American Egg Board in the 1970s rings truer than ever. Here’s why: scientists at the Roslin Institute (Midlothian, Scotland), part of the University of Edinburgh, recently...

read more

Medical Devices & Diagnostics

An Epigenetic Liquid Biopsy

An Epigenetic Liquid Biopsy

A New Type of Liquid Biopsy Biopsy. It can bring to mind painful cutting, punching and poking. Thankfully, these important and potentially life-saving procedures have moved into the new millennium along with the rest of us. Liquid biopsies have become a hot area of...

read more